Prostate cancer risk reduction: promising prevention practices and insights
- PMID: 40852019
- PMCID: PMC12369773
- DOI: 10.1097/MS9.0000000000003451
Prostate cancer risk reduction: promising prevention practices and insights
Abstract
Prostate cancer is among the leading causes of cancer-related morbidity and mortality in men worldwide. Despite advancements in diagnostic and therapeutic approaches, prevention remains a critical strategy to curb its prevalence. This review examines promising prevention practices, including lifestyle modifications, dietary interventions, and the use of chemopreventive agents. It also delves into emerging insights from genetic, epigenetic, and molecular studies, offering a comprehensive framework for reducing prostate cancer risk through tailored and evidence-based approaches. Lifestyle changes, such as maintaining a healthy weight, engaging in regular physical activity, and adopting a plant-based diet, have shown substantial potential in mitigating prostate cancer risk. Specific dietary components, like antioxidants found in fruits and vegetables and omega-3 fatty acids in fish, demonstrate protective properties, while reducing the intake of red and processed meats is encouraged. Chemopreventive agents, including 5-alpha reductase inhibitors and anti-inflammatory medications, offer additional strategies but require careful assessment of risks and benefits.
Keywords: lifestyle modifications; nutritional strategies; prevention; prostate cancer; risk reduction.
Copyright © 2025 The Author(s). Published by Wolters Kluwer Health, Inc.
Conflict of interest statement
The authors declare that they have no competing interests.
References
-
- Obeagu EI. Prevention and early detection of prostate cancer. Int J Curr Res Med Sci 2023;9:20–24.
-
- Obeagu EI, Amilo GI, Obeagu GU, et al. Evaluation of impact of level of prostate specific antigen on haematological parameters of men in Owerri, Nigeria. J Biomed Sci Appl 2017;1:3.
-
- Obeagu EI, Awil MA, Obeagu GU. Prostate cancer: prevention, risk factors, pathophysiology. J Biomed Innovation 2023;12:437–42.
-
- Ozims S, Agu G, Amah H, et al. Prevalence of prostate enlargement among males >50 years of age who were treated at Abia State University Teaching Hospital, Aba from 2010-2014. Int J Res Studies in Med Health Sci 2018;3:1–7.
-
- Nnatuanya IN, Obeagu EI, Nwakulite A, et al. Evaluation of C-reactive proteins in benign prostatic hyperplasia (BPH) subjects. Madonna University J Med Health Sci ISSN: 2814-3035 2022;2:239–48.
Publication types
LinkOut - more resources
Full Text Sources